These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 15005963)

  • 41. Ceftriaxone-associated biliary pseudolithiasis in children: do we know enough?
    Cuzzolin L; Oggiano AM; Clemente MG; Locci C; Antonucci L; Antonucci R
    Fundam Clin Pharmacol; 2021 Feb; 35(1):40-52. PubMed ID: 32492204
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ceftriaxone-associated gallbladder lithiasis in children.
    Stabile A; Ferrara P; Marietti G; Maresca G
    Eur J Pediatr; 1995 Jul; 154(7):590. PubMed ID: 7556332
    [No Abstract]   [Full Text] [Related]  

  • 43. [A case of ceftriaxone-associated pseudolithiasis in an adult patient that disappeared after the discontinuation of ceftriaxone].
    Tomoda T; Ueki T; Saito S; Tatsukawa M; Nawa T; Hamamoto H; Endo H; Yabushita K; Shimoe T; Sakaguchi K
    Nihon Shokakibyo Gakkai Zasshi; 2013 Aug; 110(8):1481-6. PubMed ID: 23912008
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ceftriaxone-associated cholelithiasis: 30 min drip infusion versus bolus injection.
    Dinleyici EC; Bor O; Kebapci M; Aydogdu SD
    Pediatr Int; 2010 Dec; 52(6):890. PubMed ID: 21166949
    [No Abstract]   [Full Text] [Related]  

  • 45. [Ceftriaxone-induced cholelithiasis--a harmless side-effect?].
    Riccabona M; Kerbl R; Schwinger W; Spork D; Millner M; Grubbauer HM
    Klin Padiatr; 1993; 205(6):421-3. PubMed ID: 8309205
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acute urine retention induced by ceftriaxone.
    Akl KF; Masri AT; Hjazeen MM
    Saudi J Kidney Dis Transpl; 2011 Nov; 22(6):1226-8. PubMed ID: 22089789
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biliary sludge and hyperbilirubinemia associated with ceftriaxone in an adult: case report and review of the literature.
    Bickford CL; Spencer AP
    Pharmacotherapy; 2005 Oct; 25(10):1389-95. PubMed ID: 16185184
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Progressive Pseudolithiasis Associated with the Intravenous Administration of Ceftriaxone in Patients with Central Nervous System Infections.
    Tsukagoshi S; Ishizawa K; Hirayanagi K; Nagamine S; Makioka K; Fujita Y; Ikeda Y
    Intern Med; 2017 Dec; 56(23):3189-3192. PubMed ID: 29021458
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sudden-onset gallbladder rupture due to Ceftriaxone-associated pseudolithiasis in a patient with acquired hemophilia A.
    Harada N; Shibano I; Mukai D; Kizawa Y; Shiragami H; Takayanagi S; Hosaka N; Mugitani A; Hino M
    J Infect Chemother; 2023 Aug; 29(8):796-799. PubMed ID: 37075980
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk Factors for Ceftriaxone-Associated Pseudolithiasis in Adults.
    Matsumi A; Tomoda T; Terasawa H; Fujii Y; Yamazaki T; Uchida D; Matsumoto K; Horiguchi S; Tsutsumi K; Kato H
    Digestion; 2023; 104(4):313-319. PubMed ID: 36907172
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Apparent biliary pseudolithiasis during ceftriaxone therapy.
    Heim-Duthoy KL; Caperton EM; Pollock R; Matzke GR; Enthoven D; Peterson PK
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1146-9. PubMed ID: 2203305
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Incidence of gallbladder lithiasis after ceftriaxone treatment.
    Cometta A; Gallot-Lavallée-Villars S; Iten A; Cantoni L; Anderegg A; Gonvers JJ; Glauser MP
    J Antimicrob Chemother; 1990 Apr; 25(4):689-95. PubMed ID: 2190975
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hemodialysis as a Risk Factor for Ceftriaxone-Associated Pseudolithiasis in Adults.
    Ubukata M; Ohsawa I; Suzuki H; Asao R; Nakamura Y; Nishida H; Nakamura M; Nitta K; Goto Y; Gotoh H
    Ther Apher Dial; 2020 Aug; 24(4):393-399. PubMed ID: 31626369
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Complications of ceftriaxone-associated biliary pseudolithiasis and neprolithiasis: a case report.
    Sienra MC; Pereira Núñez D; Pacheco H; Juambeltz C
    Cir Pediatr; 2020 Jul; 33(3):149-152. PubMed ID: 32657101
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Safety and tolerability of ertapenem versus ceftriaxone in a double-blind study performed in children with complicated urinary tract infection, community-acquired pneumonia or skin and soft-tissue infection.
    Arguedas A; Cespedes J; Botet FA; Blumer J; Yogev R; Gesser R; Wang J; West J; Snyder T; Wimmer W;
    Int J Antimicrob Agents; 2009 Feb; 33(2):163-7. PubMed ID: 18945594
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Symptomatic pseudolithiasis caused by Rocephalin].
    Tuckuviene R; Myrtue GS
    Ugeskr Laeger; 2000 Aug; 162(32):4271-2. PubMed ID: 10962947
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ceftriaxone-induced symptomatic pseudolithiasis mimicking ICP elevation.
    Evliyaoglu C; Kizartici T; Bademci G; Unal B; Keskil S
    Zentralbl Neurochir; 2005 May; 66(2):92-4. PubMed ID: 15846537
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anuria and abdominal pain induced by ceftriaxone-associated ureterolithiasis in adults.
    Li ZL; Li HL; Chen HW; Li HC; Zhang P; Wang ZM; Chong T
    Int Urol Nephrol; 2013 Feb; 45(1):73-6. PubMed ID: 23180444
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy.
    Wells WG; Woods GL; Jiang Q; Gesser RM
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii67-74. PubMed ID: 15150185
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nephrolithiasis in a child with acute pyelonephritis. Ceftriaxone-induced nephrolithiasis and biliary pseudolithiasis.
    Tasic V; Sofijanova A; Avramoski V
    Pediatr Nephrol; 2005 Oct; 20(10):1510-1, 1512-3. PubMed ID: 16082553
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.